Artivion, Inc.

    Jurisdiction
    United States
    LEI
    549300YTKV8DMSMG6K81
    ISIN
    US2289031005 (CRY)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    46 / 100
    Worse than peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    6 / 7

    Profile

    Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. Read full profile

    Fundamentals

    Net revenue
    €332.72M
    Gross margin
    63.9%
    EBIT
    €13.40M
    EBIT margin
    4.0%
    Net income
    -€18.25M
    Net margin
    -5.5%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €413.93M +24.4% €17.42M -195.4%
    N/A €29.28M +68.1%
    €511.81M €39.66M +35.5%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.03
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Stanton Marshall S. SVP, Clinical & MD Affair -18K $44.02 -$801.16K
    Holloway Jean F SVP, General Counsel -10K $44.37 -$443.70K
    Mackin James P President & CEO -13K $42.32 -$529.00K
    Davis John E Chief Commercial Officer -11K $43.67 -$471.72K
    Holloway Jean F SVP, General Counsel -23K $43.01 -$1.00M

    Earnings Calls

    Earnings Calls

    Latest earnings call: August 8, 2025 (Q2 2025)

    Add to watchlist

    Notifications